In the BioHarmony Drug Report Database

"Preview" Icon

Irbesartan

Avapro, Aprovel, Irbesartan Winthrop, Irbesartan Zentiva, Karvea (irbesartan) is a small molecule pharmaceutical. Irbesartan was first approved as Avapro on 1997-08-26. It is used to treat diabetic nephropathies, hypertension, and left ventricular dysfunction in the USA. It has been approved in Europe to treat hypertension. It is known to target sodium/bile acid cotransporter and type-1 angiotensin II receptor.

 

Trade Name

 

Aprovel, Irbesartan Winthrop, Irbesartan Zentiva, Karvea
 

Common Name

 

irbesartan
 

ChEMBL ID

 

CHEMBL1513
 

Indication

 

diabetic nephropathies, hypertension, left ventricular dysfunction
 

Drug Class

 

Angiotensin II receptor antagonists

Image (chem structure or protein)

Irbesartan structure rendering